Like all transcription factors, p53 employs positively charged side chains to interact with the polyanionic DNA backbone, and mutations of Arg residues (such as R248Q and R273H; Figure 1) are a recurrent theme in human cancers (Table 1). This evidence concerns the gene TP53 and cancer.